Research news

Search news

Browse by category

Browse:

Select all - Clear all
Monash University news

Technology based on Monash research licensed by PureTech Health to Boehringer Ingelheim

Collaboration will use technology licensed to PureTech Health to develop Boehringer Ingelheim’s novel immuno-oncology product candidates

MIPS maintains top score in 2018 ERA rankings

The Monash Institute of Pharmaceutical Sciences has again received excellent results in the latest Excellence in Research for Australia (ERA) rankings.

Denise

Breakthrough could lead to better drugs to tackle diabetes and obesity

Breakthrough research at Monash University has shown how different areas of major diabetes and obesity drug targets can be ‘activated’, guiding future drug development and better treatment of diseases.

Medicine & health
Associate Professor Bernard Flynn

From lab to industry, Monash-linked start up attracts $7M investment

Drug discovery research at Monash has underpinned a new spin out company to develop therapies for metabolic syndrome and type-2 diabetes-related diseases.

Medicine & health

Monash led study of 1000+ heavy smokers reveals an undiagnosed burden of COPD

Chronic obstructive pulmonary disease (COPD) is the fifth leading cause of death in Australia, with 7.5% of Australians over the age of 40 years experiencing moderate to severe forms of the disease. Smoking is the main cause of COPD, with as many

Faculty success in major Commonwealth grant programs

The Monash Faculty of Pharmacy and Pharmaceutical Sciences has been awarded nearly $20 million dollars in research funding in the recent rounds of grants announced by the National Health and Medical Research Council (“NHMRC”) and the

Three MIPS researchers recognised by British Pharmacological Society

Three researchers from the Drug Discovery Biology theme at the Monash Institute of Pharmaceutical Sciences have received prestigious awards from the British Pharmacological Society.

MIPS researcher wins prestigious Heart Foundation Award

Dr Lauren May, of the Drug Discovery Biology research theme at the Monash Institute of Pharmaceutical Science, has received a Heart Foundation Future Leaders Fellowship and Paul Korner Innovation Award.

Research to tackle mental illness bolstered with $10 million

Research focused on improving mental health treatment and care has been recognised with major funding grants announced by the Federal Government today.

More than $53 million in funding across 47 mental health projects was announced by the